TRULEUM, INC.

2024 Q2 Form 10-K Financial Statement

#000143774924011131 Filed on April 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $5.218K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $115.8K
YoY Change -44.46%
LONG-TERM ASSETS
Property, Plant & Equipment $43.51K
YoY Change -36.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.858M
YoY Change 21.51%
TOTAL ASSETS
Total Short-Term Assets $115.8K
Total Long-Term Assets $1.858M
Total Assets $1.974M
YoY Change 13.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.412M
YoY Change 96.31%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.412M
Total Long-Term Liabilities
Total Liabilities $4.722M
YoY Change 60.68%
SHAREHOLDERS EQUITY
Retained Earnings -$9.341M
YoY Change 34.31%
Common Stock $21.74K
YoY Change 0.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.748M
YoY Change
Total Liabilities & Shareholders Equity $1.974M
YoY Change 13.59%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
Yes
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
24211344 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21788178
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1338624 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2748004 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1742040 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1292498 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-2006903 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1667824 usd
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000855787
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
5218 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
95362 usd
CY2023Q4 aphe Joint Interest Billing Receivable Current
JointInterestBillingReceivableCurrent
21284 usd
CY2022Q4 aphe Joint Interest Billing Receivable Current
JointInterestBillingReceivableCurrent
31492 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
89320 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
81690 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
115822 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
208544 usd
CY2023Q4 us-gaap Oil And Gas Property Successful Effort Method Net
OilAndGasPropertySuccessfulEffortMethodNet
1814363 usd
CY2022Q4 us-gaap Oil And Gas Property Successful Effort Method Net
OilAndGasPropertySuccessfulEffortMethodNet
1460674 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1857876 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1548694 usd
CY2023Q4 us-gaap Assets
Assets
1973698 usd
CY2022Q4 us-gaap Assets
Assets
1757238 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
136100 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
22183 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
957458 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1210000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1210000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3411797 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1895215 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
5938 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
918 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4721702 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3095862 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21742178
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21742178
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21653326
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21653326
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
21742 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
21653 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6571011 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5731830 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9340757 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7092107 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2748004 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1338624 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1973698 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1757238 usd
CY2023 us-gaap Revenues
Revenues
146270 usd
CY2022 us-gaap Revenues
Revenues
198444 usd
CY2023 aphe Lease Operating Expenses
LeaseOperatingExpenses
411133 usd
CY2022 aphe Lease Operating Expenses
LeaseOperatingExpenses
573770 usd
CY2023 us-gaap Gross Profit
GrossProfit
-264863 usd
CY2022 us-gaap Gross Profit
GrossProfit
-375326 usd
CY2023 us-gaap Legal Fees
LegalFees
540544 usd
CY2022 us-gaap Legal Fees
LegalFees
407765 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
496010 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
156000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
705486 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
728733 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023 us-gaap Interest Expense
InterestExpense
241747 usd
CY2022 us-gaap Interest Expense
InterestExpense
224077 usd
CY2023 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
171712 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-241747 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-52365 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-2248650 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1720189 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
21710349
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
19802657
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21710349
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19802657
CY2023 aphe Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
354260 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
485010 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-2248650 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2613460 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2504500 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
308720 usd
CY2022 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
181805 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1720189 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1338624 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-2248650 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1720189 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
485010 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
308720 usd
CY2023 us-gaap Depreciation
Depreciation
54581 usd
CY2022 us-gaap Depreciation
Depreciation
8929 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
104238 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
99346 usd
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5020 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
0 usd
CY2023 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-0 usd
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
171712 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10208 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31492 usd
CY2023 aphe Increase Decrease In Prepaids And Other Current Assets
IncreaseDecreaseInPrepaidsAndOtherCurrentAssets
7630 usd
CY2022 aphe Increase Decrease In Prepaids And Other Current Assets
IncreaseDecreaseInPrepaidsAndOtherCurrentAssets
57940 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
727582 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
52308 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
25885 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
87423 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
113917 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-39207 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-683839 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1463814 usd
CY2023 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
10074 usd
CY2022 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
72566 usd
CY2023 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
353689 usd
CY2022 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
1314883 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-363763 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1387449 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
957458 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
120236 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
10000 usd
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
-0 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
168328 usd
CY2023 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
0 usd
CY2022 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
500000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2504500 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
957458 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2946408 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-90144 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
95145 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
95362 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
217 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5218 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
95362 usd
CY2023 us-gaap Interest Paid
InterestPaid
32419 usd
CY2022 us-gaap Interest Paid
InterestPaid
133826 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 aphe Discount On Convertible Debt Related Party
DiscountOnConvertibleDebtRelatedParty
0 usd
CY2022 aphe Discount On Convertible Debt Related Party
DiscountOnConvertibleDebtRelatedParty
208476 usd
CY2023 aphe Extinguishment Of Derivative Liability
ExtinguishmentOfDerivativeLiability
354260 usd
CY2022 aphe Extinguishment Of Derivative Liability
ExtinguishmentOfDerivativeLiability
181805 usd
CY2022Q4 aphe Cumulative Operating Loss Carryforwards Net
CumulativeOperatingLossCarryforwardsNet
4029000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0463 pure
CY2023Q4 us-gaap Gas Imbalance Asset Liability
GasImbalanceAssetLiability
0 usd
CY2022Q4 us-gaap Gas Imbalance Asset Liability
GasImbalanceAssetLiability
0 usd
CY2023 us-gaap Revenues
Revenues
146270 usd
CY2022 us-gaap Revenues
Revenues
198444 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
411133 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
573770 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Concentrations of Risk</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has 100 % of the working interest in the oil and gas leases, which are located in the state of Colorado and Oklahoma. Environmental and regulatory factors within the state beyond the control of the Company may limit the Company’s future production of all its leases.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has a single buyer for the gas produced from one of its leases. The loss of this buyer would have a material adverse impact on our business.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
5938 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
918 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1485000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1033000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2563 pure
CY2023Q4 aphe Cumulative Operating Loss Carryforwards Net
CumulativeOperatingLossCarryforwardsNet
5793000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1485000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1033000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1485000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1033000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
453000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
408000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-453000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-408000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5793000 usd
CY2023Q4 aphe Capital Stock Shares Authorized
CapitalStockSharesAuthorized
75000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
134145
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.86
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
134145
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.86
CY2023Q3 us-gaap Share Price
SharePrice
2.01
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
5
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y9M18D
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2504500
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2504500 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 aphe Debt Instruments Convertible Discount Rate To Weighted Price Average
DebtInstrumentsConvertibleDiscountRateToWeightedPriceAverage
0.10 pure
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2783988 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
703430 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q4 aphe Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
0 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
3487418 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2022 us-gaap Gain On Derivative Instruments Pretax
GainOnDerivativeInstrumentsPretax
171712 usd

Files In Submission

Name View Source Status
0001437749-24-011131-index-headers.html Edgar Link pending
0001437749-24-011131-index.html Edgar Link pending
0001437749-24-011131.txt Edgar Link pending
0001437749-24-011131-xbrl.zip Edgar Link pending
a01.jpg Edgar Link pending
a02.jpg Edgar Link pending
a03.jpg Edgar Link pending
a04.jpg Edgar Link pending
a05.jpg Edgar Link pending
a06.jpg Edgar Link pending
a07.jpg Edgar Link pending
a08.jpg Edgar Link pending
a09.jpg Edgar Link pending
a10.jpg Edgar Link pending
a11.jpg Edgar Link pending
a12.jpg Edgar Link pending
a13.jpg Edgar Link pending
a14.jpg Edgar Link pending
a15.jpg Edgar Link pending
a16.jpg Edgar Link pending
a17.jpg Edgar Link pending
a18.jpg Edgar Link pending
a19.jpg Edgar Link pending
a20.jpg Edgar Link pending
a21.jpg Edgar Link pending
a22.jpg Edgar Link pending
a23.jpg Edgar Link pending
a24.jpg Edgar Link pending
a25.jpg Edgar Link pending
a26.jpg Edgar Link pending
a27.jpg Edgar Link pending
a28.jpg Edgar Link pending
a29.jpg Edgar Link pending
a30.jpg Edgar Link pending
a31.jpg Edgar Link pending
a32.jpg Edgar Link pending
a33.jpg Edgar Link pending
a34.jpg Edgar Link pending
a35.jpg Edgar Link pending
a36.jpg Edgar Link pending
a37.jpg Edgar Link pending
aphe-20231231.xsd Edgar Link pending
aphe20231231_10k.htm Edgar Link pending
ex_642545.htm Edgar Link pending
ex_642546.htm Edgar Link pending
ex_642547.htm Edgar Link pending
ex_642548.htm Edgar Link pending
ex_647906.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
paulsig.jpg Edgar Link pending
pinnlogo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
aphe-20231231_def.xml Edgar Link unprocessable
aphe-20231231_pre.xml Edgar Link unprocessable
aphe20231231_10k_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
aphe-20231231_cal.xml Edgar Link unprocessable
aphe-20231231_lab.xml Edgar Link unprocessable